fda warning letters glp-1 september 2025 news Trends In FY NCL Issues a Second Alert

Consider using retinoids to help decrease signs of skin aging

Cagrilintide vs semaglutide (Wegovy/Ozempic) Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways Weight loss: Cagrilintide alone: 10-12% Semaglutide alone: 10-15% Similar efficacy monotherapy Gastric emptying: Cagrilintide: Very strong delay Semaglutide: Moderate delay Cagrilintide more powerful Side effects: Cagrilintide: More GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Cagrilintide harder to tolerate for some Availability: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved, widely available Semaglutide easier to obtain currently Combination potential: Synergistic together (CagriSema) 15-25% weight loss combined Best of both mechanisms Verdict: Similar monotherapy efficacy, but combine for maximum results

Value When considering value, we place a higher value on brands that source their ingredients in America and have certifications, such as Informed Choice

At ReGen Medical, we prescribe Ozempic (semaglutide) at dosages that are for weight loss with options to add prescriptions that increase metabolism and burn fat

Almost three months usingjust had my eye exam last weekvision improved by .25 and no more astigmatism, they said

Combination skin